Incidental mesangial IgA deposition in minimal change nephrotic syndrome (MCNS)

Japanese Journal of Nephrology

Volumn 45, Issue 7, 2003, Pages 681-688

  Tsukada, Misao ^a   Honda, Kazuho ^a   Nitta, Kosaku ^a   Yumura, Wako ^b   Nihei, Hiroshi ^b  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NONE

Author keywords

C3; Deposition; IgA; MCNS; Mesangium; Microhematuria; Serum IgA

Indexed keywords

COMPLEMENT COMPONENT C3; IMMUNOGLOBULIN A; PREDNISOLONE; STEROID;

ADULT; ARTICLE; CLINICAL FEATURE; DRUG DOSE REDUCTION; ERYTHROCYTE COUNT; FEMALE; HEMATURIA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN DEPOSITION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MESANGIUM; MINIMAL CHANGE NEPHROTIC SYNDROME; NEPHROTIC SYNDROME; PATHOLOGY; PROTEINURIA; STEROID THERAPY;

ADULT; FEMALE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; IMMUNOGLOBULIN A; MALE; NEPHROSIS, LIPOID;

EID: 0242542351     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Berger J, Hinglais N. Les depots intercapillaires d'IgA-IgG. J Urol Nephrol 1968; 74: 694-695.
2. Sinniah R. Occurrence of mesangial IgA and IgM deposits in a control necropsy population. Transplantation 1978; 26: 430-433.
3. Varis J, Rantala I, Pasternack A, Oksa H, Jantti M, Paunu ES, Pirhonen R. Immunoglobulin and complement deposition in glomeruli of 756 subjects who had committed suicide or met with a violent death. J Clin Pathol 1993; 46: 607-610.
4. Suzuki K, Honda K, Tanabe K, Toma H, Nihei H, Yamaguchi Y. Incidence of latent mesangial IgA deposition in renal allograft donors in Japan. Kidney Int 2003; 63: (in press).
5. Lai KN, Lai FM, Chan KW, Ho CP, Leung AC, Vallance-Owen J. An overlapping syndrome of IgA nephropathy and lipoid nephrosis. Am J Clin Pathol 1986; 86: 716-723.
6. Fukushi K, Yanabe H, Ozawa K, Kubota H, Ozawa H, Chiba N, Onodera K, Oike Y. Steroid responsive nephritic syndrome with glomerular IgA deposits; Clinicopathological evaluation. Jp J Nephrol 1988; 30: 253-258.
7. Clive DM, Galvanek EG, Silva FG. Mesangial immunoglobulin A deposits in minimal change nephritic syndrome: a report of an older patient and review of the literature. Am J Nephrol 1990; 10: 31-36.
8. Gallego N, Gonzalo A, Mampaso F, Ortuo J. Steroid-dependent nephritic syndrome with minimal glomerular change and mesangial IgA deposits. Child Nephrol Urol 1989; 9: 98-100.
9. Belgiojoso GB, Mezzucco G, Gassnov S, Raedelli L, Monga G, Minetti L. Steroid-sensitive nephrotic syndrome with mesangial IgA deposits: a separate entity? Observation of two cases. Am J Nephrol 1986; 6: 141-145.
10. Sinnassamy P, O'Regan. Mesangial IgA deposits with steroid responsive nephrotic syndrome: probable minimal lesion nephrosis. Am J Kidney Dis 1985; 5: 267-269.
11. Mustonen J, Pediatric A, Rantala I. The nephritic syndrome in IgA glomerulonephritis: response to corticosteroid therapy. Clin Nephrol 1983; 20: 172-176.
12. Suzuki Y, Ra C, Saito K, Horikoshi S, Hasegawa S, Tsuge T, Okumura K, Tomino Y. Expression and physical association of Fc alpha receptor and Fc receptor gamma chain in human mesangial cells. Nephrol Dial Transplant 1999; 14: 1117-1123.
13. Barratt J, Greer MR, Pawluczyk IZ, Allen AC, Bailey EM, Buck KS, Feehally J. Identification of a novel Fc alpha receptor expressed by human mesangial cells. Kid Int 2000; 57: 1936-1948.
14. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgAl with galactose-deficient hinge region and antiglycan antibodies. J Clin Inv 1999; 104: 73-81.
15. Hiki Y, Tanaka A, Kokubo T, Iwase H, Nishikido J, Hotta K, Kobayashi Y. Analyses of IgAl hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, [Clinical Trial. Controlled Clinical Trial. J Am Soc Nephrol 1998; 9; 577-582.
16. Hiki Y, Kokubo T, Iwase H, Masaki Y, Sano T, Tanaka A, Toma K, Hotta K, Kobayashi Y. Underglycosylation of IgAl hinge plays a certain role for its glomerular deposition in IgA nephropathy. J Am Soc Nephrol 1999; 10: 760-769.
17. Yano N, Asakura K, Endoh M, Abe Y, Nomoto Y, Sakai H, Kurokawa K, Tsukamoto H. Polymorphism in the Iα l germ-line transcript regulatory region and IgA productivity in patients with IgA nephropathy. J Immunol 1998; 160: 4936-4942.
18. Nakamoto Y, Iida H, Kobayashi K, Dohi K, Kida H, Hattori N, Takeuchi J. Hepatic glomerulonephritis. Characteristics of hepatic IgA glomerulonephritis as the major part. Virchows Archiv. A. Pathological Anatomy & Histology 1981; 392: 45-54.
19. Endo Y, Hara M. Glomerular IgA deposition in pulmonary diseases. Kidney Int 1986; 29: 557-562.
20. Cheng IKP, Chan KW, Chan MK. Mesangial IgA nephropathy with steroid-responsive nephrotic syndrome: disappearance of mesangial IgA deposits following steroid induced remission. Am J Kidney Dis 1989; 14: 361-364.
21. Fukushi K, Yamade H, Ozawa K, Chiba N, Inuma H, Seino S, Miyata M, Onodera K. Disappearance of glomerular IgA deposits in steroid-responsive nephrotic syndrome. Nephron 1989; 51: 553-554.
22. Kobayashi Y, Hiki Y, Kokubo T, Tateno S. Steroid therapy during the early stage of progressive IgA nephropathy. Nephron 1996; 72: 237-242.